Rock Springs Capital Management LP Biocryst Pharmaceuticals Inc Transaction History

Rock Springs Capital Management LP

$2.94 Billion
Q3 2024

A detailed history of Rock Springs Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Rock Springs Capital Management LP holds 3,622,358 shares of BCRX stock, worth $27.4 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

3,622,358

Previous 3,619,258 0.09%

Holding current value

$27.4 Million

Previous $22.4 Million 23.08%

% of portfolio

0.94%

Previous 0.69%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $19,871 - $26,939	3,100 Added 0.09%	3,622,358 $27.5 Million
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $507,998 - $835,183	123,002 Added 3.52%	3,619,258 $22.4 Million
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $1.1 Million - $1.73 Million	225,875 Added 6.91%	3,496,256 $17.8 Million
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $3.58 Million - $4.87 Million	719,155 Added 28.19%	3,270,381 $19.6 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $362,561 - $427,941	54,033 Added 2.16%	2,551,226 $18.1 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $1.14 Million - $1.44 Million	163,108 Added 6.99%	2,497,193 $17.6 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $3.52 Million - $5.25 Million	443,348 Added 23.45%	2,334,085 $19.5 Million
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $1.87 Million - $2.53 Million	178,230 Added 10.41%	1,890,737 $21.7 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $2.71 Million - $3.72 Million	251,416 Added 17.21%	1,712,507 $21.6 Million
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $11.5 Million - $26.1 Million	1,461,091 New	1,461,091 $15.5 Million
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $2.04 Million - $6.41 Million	-700,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $2.48 Million - $3.6 Million	450,000 Added 180.0%	700,000 $5.34 Million
Q2 2018 Aug 14, 2018	SELL	$4.6 - $6.52 $3.1 Million - $4.4 Million	-675,000 Reduced 72.97%	250,000 $1.43 Million
Q1 2018 May 15, 2018	BUY	$4.35 - $5.82 $489,374 - $654,750	112,500 Added 13.85%	925,000 $4.41 Million
Q4 2017 Feb 14, 2018	BUY	$4.16 - $5.33 $1.51 Million - $1.93 Million	362,500 Added 80.56%	812,500 $3.99 Million
Q3 2017 Nov 14, 2017	BUY	$4.1 - $5.97 $1.84 Million - $2.69 Million	450,000	450,000 $2.36 Million

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account

Rock Springs Capital Management LP Biocryst Pharmaceuticals Inc Transaction History